Who owns Corcept Therapeutics Incorporated?

Key details on Corcept Therapeutics Incorporated (Ticker: CORT)

Who owns Corcept Therapeutics Incorporated?

Is CORT a good stock to own? Find out who bought Corcept Therapeutics Incorporated, who sold Corcept Therapeutics Incorporated (CORT) stock, and who holds a large position in Corcept Therapeutics Incorporated.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 12.23M $53.34M March 31, 2014
TimesSquare Capital Management 4.10M $11.45M Sept. 30, 2012
Investor AB 3.45M $15.06M March 31, 2014
Credit Suisse AG 2.73M $7.61M Sept. 30, 2012
BlackRock Institutional Trust Company, N.A. 2.32M $10.13M March 31, 2014
Jennison Associates 2.15M $9.38M March 31, 2014
Vanguard 2.13M $9.28M March 31, 2014
BlackRock Fund Advisors 1.49M $6.49M March 31, 2014
MORGAN STANLEY 1.49M $6.48M March 31, 2014
First Eagle Investment Management 991978 $3.19M Dec. 31, 2013
STATE STREET CORPORATION 797148 $3.48M March 31, 2014
TCW 718786 $1.03M Dec. 31, 2012
NORTHERN TRUST 656126 $2.85M March 31, 2014
Adage Capital Partners GP 655984 $1.13M June 30, 2013
Deerfield Management Company 540000 $772200 Dec. 31, 2012
Technical Financial Services 502989 $2.19M March 31, 2014
S.A.C. Capital Advisors 500000 $795000 Sept. 30, 2013
Green Arrow Capital Management 400000 $1.74M March 31, 2014
DIMENSIONAL FUND ADVISORS 387407 $1.69M March 31, 2014
Geode Capital Management 352384 $1.54M March 31, 2014
UBS AG 330454 $571685 June 30, 2013
Hambrecht & Quist Capital Management 250000 $855000 Dec. 31, 2011

Who sold Corcept Therapeutics Incorporated?

Fund Name Date Sold Number of Shares Sold Share Valuation
Bridger Management Sept. 30, 2011 559218 $1.73M
Franklin Resources June 30, 2011 539675 $2.15M
Ayer Capital Management March 31, 2011 657000 $2.79M
Maverick Capital June 30, 2008 584763 $1.15M